Richard Engel, NBC News’ chief foreign correspondent, announced on Twitter Thursday morning that his son, Henry, has passed away.
“Our beloved son Henry passed away. He had the softest blue eyes, an easy smile and a contagious giggle. We always surrounded him with love and he returned it, and so much more. Mary and Richard, ”his post by him read.
Henry suffered from a genetic disorder known as Rett syndrome, which is usually present in girls and occurs when genes on the x-chromosome mutate. The six-year-old was diagnosed was still an infant in 2017. The disorder affects cognitive and motor skills and prevents the brain from making connections after learning new abilities such as speech. Due to the rarity of the mutation in boys, Henry’s condition provided new insights for researchers that could help others affected by Rett syndrome in the future.
On May 31, Engel tweeted that Henry had “taken a turn for the worse. His condition progressed and he’s developed dystonia: uncontrolled shaking / stiffness. He was in the hospital for 6 weeks, but is now and getting love from brother Theo.”
In 2018, Engel told Today that he and his wife Mary Forrest began to notice early on that Henry wasn’t developing at a normal rate. He struggled to talk, walk and even sit up straight as he neared his second birthday.
In an essay penned Earlier this year, Engel wrote about how valuable school in the pre-pandemic era was for Henry.
“The kids would come up and kiss him, tussle his hair and bring him toys,” Richard explained in part. “He did not always respond as they expected, but the excitement in his eyes told them he enjoyed and appreciated it. Special needs kids have the most expressive eyes.”
Researches hope to use Henry’s case to better treat others affected by Rett syndrome moving forward. Engel wrote in a follow-up Tweet on Thursday that “researchers are making amazing progress using Henry’s cells to help cure RETT Syndrome so others don’t have to endure this terrible disease.” Engel also encouraged his followers from him to support the research being done at the Texas Children’s Hospital.